Legal & General Group PLC Cyclerion Therapeutics, Inc. Transaction History

Legal & General Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$2.18 - $4.29 $4,257 - $8,378	-1,953 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.69 - $5.12 $48,514 - $92,339	-18,035 Reduced 90.23%	1,953 $5,000
Q4 2020 Feb 12, 2021	BUY	$2.25 - $7.12 $38,857 - $122,962	17,270 Added 635.39%	19,988 $61,000
Q3 2020 Nov 13, 2020	SELL	$3.46 - $8.39 $2,515 - $6,099	-727 Reduced 21.1%	2,718 $17,000
Q2 2020 Aug 14, 2020	SELL	$2.37 - $7.14 $3,272 - $9,860	-1,381 Reduced 28.62%	3,445 $21,000
Q1 2020 May 14, 2020	SELL	$2.46 - $5.84 $3,070 - $7,288	-1,248 Reduced 20.55%	4,826 $12,000
Q4 2019 Feb 13, 2020	BUY	$1.8 - $13.43 $1,616 - $12,060	898 Added 17.35%	6,074 $16,000
Q3 2019 Nov 13, 2019	SELL	$8.12 - $14.54 $23,174 - $41,497	-2,854 Reduced 35.54%	5,176 $63,000
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $77,088 - $183,485	8,030 New	8,030 $92,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $140M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.